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Clinics and pathology 
Disease 
Treatment related acute non lymphoblastic leukemia (t-
ANLL). 
Phenotype/cell stem origin 
M5b ANLL. 
Epidemiology 
Only one case; a female patient aged 23 yrs and treated 
9 years ago for T-ALL. 
Prognosis 
Unknown; likely to be poor, both as it carries a MLL 









13-15 kb mRNA. 
Protein 
431 kDa; contains two DNA binding motifs (a AT  
hook, and Zinc fingers), a DNA methyl transferase 
motif, a bromodomain; transcriptional regulatory 








Breakpoints of MLL between exons 9 and 10 and 
upstream of exon 1 of the AF3p21 gene. 
Fusion protein 
Description 
AT hooks and methyltransferase domains of MLL in 
the N-term fused to the proline-rich domain and nuclear 
localization signal of AF3p21. 
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